|
|
| | L-Leucinamide, N,N-dimethyl-L-isoleucyl-(2S)-2-hydroxy-4-methylpentanoyl-N-[(1S,2E)-4-[(2S)-2,5-dihydro-3-methoxy-2-methyl-5-oxo-1H-pyrrol-1-yl]-1-methyl-4-oxo-2-buten-1-yl]- Basic information |
| | L-Leucinamide, N,N-dimethyl-L-isoleucyl-(2S)-2-hydroxy-4-methylpentanoyl-N-[(1S,2E)-4-[(2S)-2,5-dihydro-3-methoxy-2-methyl-5-oxo-1H-pyrrol-1-yl]-1-methyl-4-oxo-2-buten-1-yl]- Chemical Properties |
| Boiling point | 747.8±60.0 °C(Predicted) | | density | 1.11±0.1 g/cm3(Predicted) | | pka | 12.76±0.46(Predicted) |
| | L-Leucinamide, N,N-dimethyl-L-isoleucyl-(2S)-2-hydroxy-4-methylpentanoyl-N-[(1S,2E)-4-[(2S)-2,5-dihydro-3-methoxy-2-methyl-5-oxo-1H-pyrrol-1-yl]-1-methyl-4-oxo-2-buten-1-yl]- Usage And Synthesis |
| Uses | Gallinamide A is a potent inhibitor of cathepsin L with an IC50 value of 17.6 pM. | | References | [1] Ashhurst AS, et al. Potent in vitro anti-SARS-CoV-2 activity by gallinamide A and analogues via inhibition of cathepsin L. bioRxiv [Preprint]. 2020 Dec 24:2020.12.23.424111. DOI:10.1101/2020.12.23.424111 |
| | L-Leucinamide, N,N-dimethyl-L-isoleucyl-(2S)-2-hydroxy-4-methylpentanoyl-N-[(1S,2E)-4-[(2S)-2,5-dihydro-3-methoxy-2-methyl-5-oxo-1H-pyrrol-1-yl]-1-methyl-4-oxo-2-buten-1-yl]- Preparation Products And Raw materials |
|